Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...
The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...
Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
Dr. Ranjit S. Bindra discusses latest developments for the remedy of sufferers with main mind tumors throughout Mind Most cancers Consciousness Month.Latest developments...
Sufferers with out TP53 mutations or liver metastases noticed longer progression-free survival with samuraciclib combos after CDK4/6 inhibitor remedy.Outcomes from two section 2...
